News
What are the cardiorenal differences between type 1 and type 2 diabetes?
- Author:
- Sara Freeman
Heart failure may be as much, if not more of, a problem in people with type 1 diabetes as type 2 diabetes, researchers suggested.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/stroke_ischemic_web2.jpg)
Estimating insulin resistance may help predict stroke, death in T2D
- Author:
- Sara Freeman
The estimated glucose disposal rate may be useful way to determine first stroke risk in type 2 diabetes.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/aspirin_low_dose_web_0.jpg)
Aspirin lowered preeclampsia risk in real-world lupus study
- Author:
- Sara Freeman
A prospective, single-center study of pregnancies during 1995-2020 showed a reduced risk for preeclampsia among high-risk women with systemic...
News
‘Multimorbidity’ more commonly seen in people with lupus
- Author:
- Sara Freeman
Two studies find that patients with either systemic or cutaneous disease have higher rates of multiple comorbidities, including those commonly...
News
Lupus may confer higher risk of death from COVID-19
- Author:
- Sara Freeman
SLE had a greater impact on mortality and other poor outcomes than did all the other comorbidities considered in a cross-sectional study of COVID-...
News
Low preconception complement levels linked to adverse pregnancy outcomes in antiphospholipid syndrome
- Author:
- Sara Freeman
Low levels of C3 and C4 in the 6 months prior to pregnancy were associated with several gestational and maternal complications and resulted in...
News
Hypoglycemia awareness program helps tricky-to-treat T1D
- Author:
- Sara Freeman
New psychoeducation program tackles problematic type 1 diabetes hypoglycemia awareness, reducing severe hypoglycemia with added mental health...
News
Cell therapy promising as long-term limb-saving treatment in diabetes
- Author:
- Sara Freeman
Fewer amputations were needed at 5 years in patients with diabetic foot and critical limb-threatening ischemia, compared with conservative...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Retinopathy risk higher in young-onset T2D, more so in men
- Author:
- Sara Freeman
Gender differences in the prevalence of retinopathy have been seen in a large Norwegian population of primary care patients with type 2 diabetes...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Ho_Frederick_GLASGOW_web.jpg)
‘Metabolically healthy obesity’ tied to substantial heart risk
- Author:
- Sara Freeman
There was an increased risk for both new-onset heart failure and atrial fibrillation in people who were obese with no metabolic abnormalities.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Patorno_Elisabetta_web.jpg)
Heart failure hospitalization risk lower with SGLT2 inhibitors than GLP-1 RAs
- Author:
- Sara Freeman
SGLT2 inhibitor versus GLP-1 RA use was associated with a significantly lower rate of hospitalization for heart failure in people with diabetes....
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Reveille_John_D_TX_web.jpg)
Early vs. late TNFi switch in AS patients associated with different risk factors
- Author:
- Sara Freeman
Different factors were associated with switching an initial TNF inhibitor within 2 years versus after 2 years of treatment.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/van der Heijde_Desiree_NETH2_web_0.jpg)
Real-world data generate debate on definition of flare in axial spondyloarthritis
- Author:
- Sara Freeman
Changes in the Bath Ankylosing Spondyloarthritis Disease Activity Index could be used to monitor patient-reported flares in axial...
News
Targeting IL-23 could still be important for axial spondyloarthritis treatment
- Author:
- Sara Freeman
Results of a systematic review and meta-analysis corroborate negative trial findings for IL-23 but hint at some early benefit with risankizumab....
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/Landewe_Robert_NETHERLANDS_web.jpg)
csDMARDs could add to TNF inhibitors’ benefits in SpA
- Author:
- Sara Freeman
EuroSpA Research Collaboration data hint at better retention and remission rates with csDMARD-TNFi cotherapy versus TNFi alone in...